In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $28.87, denoting a +0.7% change from the preceding trading day.

We recently published a list of 10 Worst Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are ...

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Q4 2024 Earnings Call Transcript February 27, 2025 Ligand Pharmaceuticals Incorporated misses on earnings expectations.

Financial markets grappled with a storm of political maneuvering around trade, taxes, and regulation, stoking some investor ...